June 30, 2023. Many scams start with an intimidating phone call. A “debt collector” needs you to pay immediately. Or a “police officer” claims to have a warrant for your arrest. The latest ...Pharmacy: 866-503-0857; Infusions *For any tests other than those listed call the health plan directly to verify authorization requirements. ... NIA (National Imaging Associates): 866-842-1767/ Prefix WMW thru AIM: 866-688-1449 ; MRI/MRA, CT/CTA, PET, Nuclear Cardiology, All Types of Echos, Infusions *For any tests otherPerform a reverse number lookup and you will be able to identify who's behind the call and decide if you should return the call or not. Connect with a long-lost friend. Through a free reserve phone number lookup, you can re-establish contact with a relative, friend from high school, former work colleague, or associate. Run a background check.1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy,Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...1-844-268-7263. PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Vabysmo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use.Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment.MEDICARE FORM. Viscosupplementation Injectable Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) Patient Last Name. Patient Phone. For Medicare Advantage Part B: Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263. For other lines of business: Please use other form.1-866-503-0857 . For other lines of business: Please use other form. Note: Stelara is non-preferred. Preferred products vary based on indication. See section G below. (Please return. Pages 1 to 3. for precertification of medications.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment ...1-866-503-0857 . For other lines of business: Please use other form. Note: Entyvio is preferred on MA (All fields must be completed and legible for precertification review.) and MAPD plans. Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment . Precertification Requested By:For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263. G. CLINICAL INFORMATION (continued) - - Required clinical information must be completed in its entirety for all precertification requests. Yes No Was the patient prescribed the requested drug due to clinical worsening after receiving gene replacement therapy (e.g ...Fasenra® (benralizumab) Injectable Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Patient First Name.Page 2 of 3. (All fields must be completed and legible for precertification review) Aetna Precertification Notification. Phone: 1-855-240-0535. FAX: 1-877-269-9916. For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263. Patient First Name.PHONE: 1-866-503-0857 For other lines of business: Please use other form. Note: Neupogen is non preferred. Zarxio is preferred. Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment.Phone: 1-866-752-7021 . FAX: ... Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By:Lucentis® (ranibizumab) Injectable Medication Precertification Request. Page 1 of 2. (All fields must be completed and legible for Precertification Review.) For Medicare Advantage Part B: FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form. Note: Lucentis is non-preferred.866-503-1875 [email protected] Contact Us; Login; Accurate, instant vehicle reports. Create Report. Make. $1 for one report (limited use) $29.95/mo for 3 months of 30 reports/mo. Why do I need a report? ONLINEDATALOOKUP.COM. Simple Sales LLC 13320 S. Mackinaw Avenue, Chicago, Illinois 606331-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Susvimo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. Precertification Requested By:Policy: Under some plans, including plans that use an open or closed formulary, Yervoy is subject to precertification. If precertification requirements apply Aetna considers Yervoy to be medically necessary for those members who meet the following precertification criteria:Continued on next page. MEDICARE FORM Stelara®(ustekinumab) Specialty Medication Precertification Request. For Medicare Advantage Part B: FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form.Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Lanreotide (Cipla) is non-preferred. The preferred products are Sandostatin LAR and Page 1 of 2 Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment:Start date1-866-503-0857 . or fax applicable request forms to . 1-888-267-3277, with the following exceptions: • For precertification of pharmacy-covered specialtydrugs (noted with*) when memberis enrolled in a commercial plan, call . 1-855-240-0535 . or fax applicable request forms to . 1-877-269-9916 • Providers can use the drug-specific503 Sunport Lane, Orlando, FL 32809. Medication Precertification Request. Phone: 1-866-503-0857. Page 1 of 2 FAX: 1-888-267-3277. (All fields must be completed and legible for Precertification Review) For Medicare Advantage Part B: Please indicate: Start of treatment: Start date / / FAX: 1-844-268-7263 Continuation of therapy: Date of last ...1-866-503-0857 . For other lines of business: Please use other form. Note: Nyvepria, Udenyca, and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Fulphila are preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentPHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product Page 1 of 3 is Eligard. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / /Specialty Medication Precertification Request - … GR-69374 (2-18)Page 1 of 2 Specialty Medication Precertification Request Aetna Precertification Notification503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B:FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.)866 503 0857. Get the up-to-date GR 68722 Medication Precertification Form - Aetna 2024 now Get Form. 4.4 out of 5. 215 votes. DocHub Reviews. 44 reviews. DocHub Reviews.1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-503-0857 . For other lines of business: Please use other form . Note: Procrit and Epogen are non-preferred. The preferred products are Aranesp and Retacrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-503-0857 . For other lines of business: Please use other form . Note: Procrit and Epogen are non-preferred. The preferred products are Aranesp and Retacrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /503 Sunport Lane, Orlando, FL 32809. Phone: 1-866-503-0857 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax:Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Lanreotide (Cipla) is non-preferred. The preferred products are Sandostatin LAR and Page 1 of 2 Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment:Start dateProviders can request prior approval using Transdev's PassPORT system or by phone at 866-503-9040. ... 800-526-0857 Voice Users 800-501-0864 TTY Spanish 800-501-0865 Voice Spanish 877-526-6680 American Standard Code for Information Exchange (ASCII) 877-526-6690 Speech-to-Speech (STS)Providers can request prior approval using Transdev's PassPORT system or by phone at 866-503-9040. ... 800-526-0857 Voice Users 800-501-0864 TTY Spanish 800-501-0865 Voice Spanish 877-526-6680 American Standard Code for Information Exchange (ASCII) 877-526-6690 Speech-to-Speech (STS)PHONE: 1-866-503-0857 . For other lines of business: Please use other form . Note: Trelstar is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatmentG. CLINICAL INFORMATION - Required clinical information must be completed for ALL precertification requests. For Initiation Requests (clinical documentation required for all requests): Note: Cimzia is non-preferred. Entyvio, Inflectra, Remicade, Simponi Aria, and unbranded infliximab are preferred for MA plans.PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product Page 1 of 3 is Eligard. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / /1-866-752-7021 acetate for depot suspension) FAX: 1-888-267-3277 Medication Precertification Request For Medicare Advantage Part B: Phone: 1-866-503-0857 Page 2 of 2 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . H. ACKNOWLEDGEMENTPhone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment. Precertification Requested By: Phone: Fax: A. PATIENT INFORMATIONSynagis™ (palivizumab ) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Refer to Medical CPB #0318 Synagis (Palivizumab) Policy: Precertification Criteria. Under some plans, including plans that use an open or closed formulary, Synagis is subject to precertification.1-866-503-0857 . For other lines of business: Please use other form. Note: Renflexis is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /There are 7.18 billion human beings on the planet today. And there are 7.07 billion mobile phone connections. But those belong to fewer than 3.6 billion unique subscribers, or just...1-866-503-0857 . For other lines of business: Please use other form. Note: Tremfya is non-preferred. Preferred products vary based on (All fields must be completed and legible for precertification review.) indication. See section G below. Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment1-866-752-7021 . FAX: 1-888-267-3277 . Page 1 of 1 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatment / / Precertification Requested By: Phone: Fax:Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date . Continuation of therapy, Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT ...Phone: 1-866-752-7021 . FAX: ... Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By:The new Roku 4 has voice recognition, 4k, and something Apple doesn't: a remote control locator so you'll never need a replacement. By clicking "TRY IT", I agree to receive newslet...Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Exception: Member's enrolled in an Individual Plan for the following pharmacy covered drugs - Actemra, Amevive, Cimzia, Cosentyx, Enbrel, Humira, Kineret, Orencia, Otezla, Simponi, Stelara, and Xeljanz please contact Aetna Pharmacy Management Precertification at 1-800-414-2386The best way to double-check that a number is a scammer is to type the number into your favorite search engine. This method is useful if your scam blocker catches a number, you accidentally hang ...Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 For other lines of business: Please use other form. Note: Fylnetra, Nyvepria, Rolvedon, Stimufend, Udenyca and Udenyca Onbody are non-preferred. Fulphila and Neulasta/Neulasta Onpro are preferred. (All fields must be completed and legible for precertification review.) Patient First NameWho is calling or texting from 866-503-0857 phone number? Reverse Phone Lookup registered owner's full name, address, public records & background check for +1 866-503-0857 with Whitepages.Free essays, homework help, flashcards, research papers, book reports, term papers, history, science, politics1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Breast implant associated anaplastic large cell lymphoma, Cutaneous anaplastic large cell lymphoma, Systemic anaplastic large cell lymphoma (ALCL)1-866-503-0857 . For other lines of business: Please use other form . Note: Epogen and Retacrit are non-preferred. The preferred products are Aranesp and Procrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentPage 1 of 1 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263. Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / /.PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Eylea and Eylea HD are non-preferred. The preferred product is bevacizumab (Avastin). Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. (All fields must be completed and legible for precertification review.)Drug. Rituxan® (rituximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. For Oral Corticosteroid Clinical policy click here. Policy: Note: The provision of physician samples does not guarantee coverage under the provisions of the pharmacy benefit.1-866-503-0857 . For other lines of business: Please use other form. Note: Lupron Depot is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. Page 1 of 3 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, last ...Phone: 1-866-752-7021. Medication Precertification Request. FAX: 1-888-267-3277. Page 1 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263. Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment ...Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / / Precertification Requested By: Phone: Fax:1-866-503-0857 (All fields must be completed and legible for precertification review) Fax: 1-888-267-3277. For Medicare Advantage Part B: Please Use Medicare Request Form . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Susvimo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. Precertification Requested By:Page 1 of 1 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263. Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / /.Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.To initiate precertification or inquire about pending precertification, call an Aetna representative toll free at 1-866-503-0857. Next-day delivery Complete orders received before 3 p.m. ET are scheduled for next-day delivery. Refills1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . FAX: 1-888-267-3277 . or Bynfezia Pen . For Medicare Advantage Part B: Phone: 1-866-503-0857 . Medication Precertification Request . FAX: 1-844-268-7263 . Page 3 of 3 (All fields must be completed and legible for precertification review) - Patient First Name . Patient Last Name . Patient ...: 1-866-503-0857 . FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Aralast NP, Glassia and Zemaira are non-preferred. The preferred product is Prolastin-C. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of ...Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 For other lines of business: Please use other form. Note: Fylnetra, Nyvepria, Rolvedon, Stimufend, Udenyca and Udenyca Onbody are non-preferred. Fulphila and Neulasta/Neulasta Onpro are preferred. (All fields must be completed and legible for precertification review.) Patient First Name1-866-503-0857 . For other lines of business: Please use other form. Note: Fulphila, Nyvepria and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last ...Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.1-866-503-0857 FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Ocrevus is non-preferred for relapsing forms of multiple sclerosis for MAPD plans. The preferred product is Kesimpta. GR-69329-3 (1-23) Page 1 of 2 (All fields must be completed and return all pages for precertification review.) Please indicate:1-866-752-7021. FAX: 1-888-267-3277. For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT ...Erythropoietin Injectable Medication Precertification Request Aranesp®/Epogen®/Procrit®. Aetna Precertification Notification 503 Sunport Lane Orlando, FL 32809 Phone: 1-866 …503 Sunport Lane, Orlando, FL 32809 . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review) Please indicate: Start of treatment: Start date: / / Continuation of therapy: Date of last treatment / /Who is calling or texting from 866-503-0857 phone number? Reverse Phone Lookup registered owner's full name, address, public records & background check for +1 866-503-0857 with Whitepages.1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . FAX: 1-888-267-3277 . or Bynfezia Pen . For Medicare Advantage Part B: Phone: 1-866-503-0857 . Medication Precertification Request . FAX: 1-844-268-7263 . Page 3 of 3 (All fields must be completed and legible for precertification review) - Patient First Name . Patient Last Name . Patient ...1-866-503-0857 . For other lines of business: Please use other form. Note: Entyvio is preferred on MA plans. On MAPD plans Entyvio is preferred for ulcerative colitis and non-preferred for Crohn's disease. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / /503 Sunport Lane, Orlando, FL 32809 . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review) Please indicate: Start of treatment: Start date: / / Continuation of therapy: Date of last treatment / /Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment, start date: / / Continuation of therapy, date of last treatment: / / Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION First Name: Last Name: Address: City: ...1-866-503-0857 . For other lines of business: Please use other form. Note: Entyvio is preferred on MA (All fields must be completed and legible for precertification review.) and MAPD plans. Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT ...1-866-503-0857 . For other lines of business: Please use other form. Note: Tremfya is non-preferred. Preferred products vary based on (All fields must be completed and legible for precertification review.) indication. See section G below. Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /Page 2 of 3. (All fields must be completed and legible for precertification review) Aetna Precertification Notification. Phone: 1-855-240-0535. FAX: 1-877-269-9916. For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263. Patient First Name.Precertification of cetuximab (Erbitux) is required of all Aetna participating providers and members in applicable plan designs. For precertification of cetuximab (Erbitux), call (866) 752-7021 or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty Pharmacy Precertification.Providers: 866-503-9040 Fax: 630-873-1450. TTY Machine: 630-873-1449 ... 800-526-0857 Voice Users 800-501-0864 TTY Spanish 800-501-0865 Voice Spanish 877-526-6680 American Standard Code for Information Exchange (ASCII) 877-526-6690 Speech-to-Speech (STS) 877-826-1130 Voice Carry Over (VCO) Users Non …Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Lanreotide (Cipla) is non-preferred. The preferred products are Sandostatin LAR and Page 1 of 2 Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment:Start date1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 2 of 2 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)How to get started. We have several ways for you to fill a prescription through the network specialty pharmacy. New prescriptions: For a new prescription, your doctor can: e-Prescribe NCPDP ID 1466033. Fax your prescription to 1-800-323-2445. Call us at 1-800-237-2767.Synagis™ (palivizumab ) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Refer to Medical CPB #0318 Synagis (Palivizumab) Policy: Precertification Criteria. Under some plans, including plans that use an open or closed formulary, Synagis is subject to precertification.PHONE: 1-866-503-0857 . For other lines of business: Please use other form. Note: Botox and Myobloc are non-preferred. The preferred products are Dysport and Xeomin. Tags: Aetna, Medication, Request, Precertification, Injectable, Toxins, Botulinum, Botulinum toxins injectable medication precertification request, Dysport.1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . FAX: 1-888-267-3277 . or Bynfezia Pen . For Medicare Advantage Part B: Phone: 1-866-503-0857 . Medication Precertification Request . FAX: 1-844-268-7263 . Page 3 of 3 (All fields must be completed and legible for precertification review) - Patient First Name . Patient Last Name . Patient ...Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date / / Continuation of therapy:Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT INFORMATION First Name: Last Name: DOB: Address: City: State: ZIP:1-866-503-0857 . For other lines of business: Please use other form. Note: Stelara is non-preferred. Preferred products vary based on indication. See section G below. (Please return. Pages 1 to 3. for precertification of medications.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment .... Page 2 of 3. (All fields must be completed and legible for precGR-68305-3 (9-23) MEDICARE FORM Immune Glob Remicade® (infliximab) Injectable Medication Precertification Request. Page 1 of 5. (All fields must be completed and legible for precertification review.) FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form. Note: Remicade is preferred for MA plans. Preferred status for.Phone: 1-866-752-7021. Medication Precertification Request. FAX: 1-888-267-3277. Page 1 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263. Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment ... Pediatric Growth Hormone Injectable Medication Precertification Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277. Policy: Note: The provision of physician samples does not guarantee coverage under the provisions of the pharmacy benefit. 1-866-752-7021 . FAX: 1-888-267-3277 . Fo...
Continue Reading